Adverse effect of other antihypertensive drugs, initial encounter. T46.5X5A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM T46.5X5A became effective on October 1, 2018.
T46- Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system 2021 ICD-10-CM Diagnosis Code T46.6X5A T46.6X5A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter 2016 2017 2018 2019 2020 2021 Billable/Specific Code T46.6X5A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Adverse effect of antihyperlip and antiarterio drugs, init
Myalgia due to statin ICD-10-CM T46.6X5A is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 791 Prematurity with major problems 793 Full term neonate with major problems
ICD-10 code T88. 7 for Unspecified adverse effect of drug or medicament is a medical classification as listed by WHO under the range - Injury, poisoning and certain other consequences of external causes .
Long term (current) use of antithrombotics/antiplatelets The 2022 edition of ICD-10-CM Z79. 02 became effective on October 1, 2021. This is the American ICD-10-CM version of Z79.
ICD-10-CM for Statin IntoleranceCardio403.Dec 14, 2017.
When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug (T36-T50).
ICD-10-CM Code for Long term (current) use of antithrombotics/antiplatelets Z79. 02.
ICD-10 code Z79. 82 for Long term (current) use of aspirin is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
As the name suggests, statin intolerance occurs when a patient is unable to continue to use a statin, either because of the development of a side effect or because of evidence on a blood test that certain markers of liver function or muscle function (creatine kinase) are sufficiently abnormal to cause concern. 2.
In patients with statin intolerance, it may be advisable to change the dose, switch to a different statin, or try an alternate-day regimen. If intolerance is associated with all statins—even at the lowest dose—non-statin drugs and certain nutraceuticals can be considered.
Now, a new study of over four million patients has shown that the true prevalence of statin intolerance worldwide is between six to ten percent.
Listen to pronunciation. (AD-vers eh-FEKT) An unexpected medical problem that happens during treatment with a drug or other therapy. Adverse effects may be mild, moderate, or severe, and may be caused by something other than the drug or therapy being given.
In ICD-10-CM, underdosing is defined as taking less of a medication than is prescribed by a provider or instructed by the manufacturer.
In the case of an adverse effect of a prescribed medication, the adverse effect is coded first, followed by coding for the substance causing the adverse effect and then the condition being treated. Encounters involving poisoning are coded in a different order first by the substance, followed by the adverse effects.
0: Drug-induced myopathy.
E78.00ICD-10 code E78. 00 for Pure hypercholesterolemia, unspecified is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
E78.5Code E78. 5 is the diagnosis code used for Hyperlipidemia, Unspecified, a disorder of lipoprotein metabolism other lipidemias. It is a condition with excess lipids in the blood.
Myalgia is a potential adverse effect of statin treatment Myalgia, with or without muscle weakness, is the most common adverse effect associated with statin use, and is reported to occur in up to 10% of people prescribed statins.
T46- Poisoning by , adverse effect of and underdosing of agents primarily affecting the cardiovascular system
The 2022 edition of ICD-10-CM T46.5X5A became effective on October 1, 2021.
poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists ( T44.7) poisoning by, adverse effect of and underdosing of calcium-channel blockers ( T46.1) poisoning by, adverse effect of and underdosing of diuretics ( T50.0- T50.2) Poisoning by, adverse effect of and underdosing of other antihypertensive drugs.
Use secondary code (s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code. Type 1 Excludes.
T46.6X5A is a billable diagnosis code used to specify a medical diagnosis of adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter. The code T46.6X5A is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.#N#The ICD-10-CM code T46.6X5A might also be used to specify conditions or terms like acipimox adverse reaction, adverse reaction caused by atorvastatin, adverse reaction caused by cerivastatin, adverse reaction caused by fluvastatin, adverse reaction caused by lovastatin , adverse reaction caused by pitavastatin, etc.#N#The code T46.6X5A describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.#N#T46.6X5A is an initial encounter code, includes a 7th character and should be used while the patient is receiving active treatment for a condition like adverse effect of antihyperlipidemic and antiarteriosclerotic drugs. According to ICD-10-CM Guidelines an "initial encounter" doesn't necessarily means "initial visit". The 7th character should be used when the patient is undergoing active treatment regardless if new or different providers saw the patient over the course of a treatment. The appropriate 7th character codes should also be used even if the patient delayed seeking treatment for a condition.
When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.
Drug allergies are another type of reaction. They can be mild or life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is more rare.
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
For codes less than 6 characters that require a 7th character a placeholder 'X' should be assigned for all characters less than 6. The 7th character must always be the 7th position of a code. E.g. The ICD-10-CM code T67.4 (Heat exhaustion due to salt depletion) requires an Episode of Care identifier.
The ICD-10-CM Drugs Index links the below-listed medical terms to the ICD code T46.6X5. Click on any term below to browse the drugs index.
For codes less than 6 characters that require a 7th character a placeholder 'X' should be assigned for all characters less than 6. The 7th character must always be the 7th position of a code. E.g. The ICD-10-CM code T67.4 (Heat exhaustion due to salt depletion) requires an Episode of Care identifier.
The ICD-10-CM Drugs Index links the below-listed medical terms to the ICD code T43.8X5. Click on any term below to browse the drugs index.
Hyperlipidemia is an umbrella term that refers to any of several acquired or genetic disorders that result in a high level of lipids (fats, cholesterol, and triglycerides) circulating in the blood.
Elevated blood lipid levels alone do not cause symptoms, except with pancreatitis (painful inflammation of the pancreas).
Treatment should begin with exercise, weight loss, a low-fat diet, and, if applicable, diabetes management. In most cases, though, more is needed. Anti-cholesterol medications (statins) is a medication that can be taken orally, usually, once a day, are extremely effective in lowering LDL and VLDL cholesterol levels.